NASDAQ:CELC

Celcuity Stock Insider Trading

Healthcare > Biotechnology

Buy CELC

*Your capital is at risk

$90.21

+0.280 (+0.311%)

At Close: Jun 23, 2026

Celcuity Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 14.50. In total, the insiders bought 14.25M and sold 579.98K CELC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	14.50
● Buy	14.25M shares
● Sell	579.98K shares
58% Buy Activity Weak Negative Correlation
Sell Signal Low Confidence May 04, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 10, 2026 Sell	Stock Option (right to buy) G-Gift	Buller Richard E Director	Director	12 503 Value: $133.7K
Jun 10, 2026 Buy	Stock Option (right to buy) G-Gift	Buller Richard E Director	Director	12 503 Value: $133.7K
Jun 10, 2026 Buy	Stock Option (right to buy) G-Gift	Murphy Polly A. Director	Director	14 048 Value: $150.2K
Jun 10, 2026 Sell	Stock Option (right to buy) G-Gift	Murphy Polly A. Director	Director	14 048 Value: $150.2K
Jun 05, 2026 Buy	Common Stock A-Award	Buller Richard E Director	Director	1 530 Value: $135.1K
Jun 05, 2026 Buy	Common Stock A-Award	Furcht Leo Director	Director	1 530 Value: $135.1K
Jun 05, 2026 Buy	Common Stock A-Award	Nigon Richard Director	Director	1 530 Value: $135.1K
Jun 05, 2026 Buy	Common Stock A-Award	Dalvey David Director	Director	1 530 Value: $135.1K
Jun 05, 2026 Buy	Common Stock A-Award	Murphy Polly A. Director	Director	1 530 Value: $135.1K
Jun 05, 2026 Buy	Common Stock A-Award	Romp Charles R Director	Director	1 530 Value: $135.1K
Jun 02, 2026 Buy	Common Stock M-Exempt	Laing Lance G. Chief Science Officer	Officer	1 000 Value: $10K
Jun 02, 2026 Buy	Stock Option (right to buy) M-Exempt	Laing Lance G. Chief Science Officer	Officer	1 000 Value: $10K
May 19, 2026 Buy	Common Stock G-Gift	Buller Richard E Director	Director	1 029 Value: $134.8K
May 19, 2026 Sell	Common Stock G-Gift	Buller Richard E Director	Director	1 029 Value: $0
May 04, 2026 Buy	Stock Option (right to buy) M-Exempt	Buller Richard E Director	Director	9 000 Value: $45.9K
May 04, 2026 Sell	Common Stock S-Sale	Buller Richard E Director	Director	365 Value: $52.3K
May 04, 2026 Sell	Common Stock S-Sale	Buller Richard E Director	Director	2 825 Value: $401.3K
May 04, 2026 Sell	Common Stock S-Sale	Buller Richard E Director	Director	2 301 Value: $324.5K
May 04, 2026 Sell	Common Stock S-Sale	Buller Richard E Director	Director	1 670 Value: $233.1K
May 04, 2026 Sell	Common Stock S-Sale	Buller Richard E Director	Director	550 Value: $76.4K
May 04, 2026 Sell	Common Stock S-Sale	Dalvey David Director	Director	25 000 Value: $3.52M
May 04, 2026 Buy	Common Stock M-Exempt	Buller Richard E Director	Director	9 000 Value: $45.9K
May 04, 2026 Sell	Common Stock S-Sale	Buller Richard E Director	Director	1 289 Value: $176.6K
Apr 09, 2026 Sell	Common Stock G-Gift	Nigon Richard Director	Director	10 000 Value: $0
Mar 31, 2026 Buy	Stock Option (right to buy) M-Exempt	Buller Richard E Director	Director	3 000 Value: $15.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CELCUITY INC

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I...

Read Full Profile Here